Bonson K R, Buckholtz J W, Murphy D L
Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, MD 20892, USA.
Neuropsychopharmacology. 1996 Jun;14(6):425-36. doi: 10.1016/0893-133X(95)00145-4.
This study investigates the possible interactions of antidepressant agents and hallucinogens in humans through structured interviews using a standardized questionnaire. Volunteer subjects recruited through announcements placed on the Internet or other sources were asked to describe the somatic, hallucinatory, and psychological effects of self-administered LSD prior to and during chronic administration of an antidepressant. Twenty-eight out of 32 subjects (88%) who had taken an antidepressant with inhibitory effects on serotonin (5-HT) reuptake (fluoxetine, paroxetine, sertraline, trazodone) for over 3 weeks had a subjective decrease or virtual elimination of their responses to LSD. An additional subject who had taken fluoxetine for only 1 week had an increased response to LSD. These data are in contrast to our previous study that reported increased responses to LSD during chronic administration of tricyclic antidepressants or lithium. Possible mechanisms of action for the effects from serotonergic antidepressants involve 5-HT2 and 5-HT1A receptors, changes in extracellular brain serotonin concentrations, and changes in brain catecholamine systems.
本研究通过使用标准化问卷进行结构化访谈,调查了抗抑郁药与致幻剂在人体中可能存在的相互作用。通过在互联网或其他渠道发布公告招募的志愿者受试者,被要求描述在长期服用抗抑郁药之前和期间自行服用麦角酸二乙酰胺(LSD)后的躯体、幻觉及心理效应。32名受试者中,有28名(88%)服用了对5-羟色胺(5-HT)再摄取有抑制作用的抗抑郁药(氟西汀、帕罗西汀、舍曲林、曲唑酮)超过3周,他们对LSD的反应主观上有所降低或几乎消失。另有一名仅服用了1周氟西汀的受试者对LSD的反应增强。这些数据与我们之前的研究结果相反,之前的研究报告称,在长期服用三环类抗抑郁药或锂盐期间,对LSD的反应增强。5-羟色胺能抗抑郁药产生效应的可能作用机制涉及5-HT2和5-HT1A受体、细胞外脑5-羟色胺浓度的变化以及脑内儿茶酚胺系统的变化。